SCHEMBL4725783

SCHEMBL4725783

CCCCCCNC1CCCN(S(=O)(=O)c2cccc3c(O)nc(I)cc23)C1

nearest known ligand 0.39

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TP53 P04637 3/20 0.37
ROCK2 O75116 1/20 0.37
ROCK1 Q13464 1/20 0.37
BRD4 O60885 1/20 0.36
HSD11B1 P28845 1/20 0.36
ALDH1A1 P00352 2/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
EPHX2 P34913 1/20 0.35
KDM4E B2RXH2 1/20 0.35
TSHR P16473 1/20 0.35
MAPK1 P28482 1/20 0.35
HTT P42858 1/20 0.35
CNR1 P21554 1/20 0.34
LMNA P02545 1/20 0.34
ADRB3 P13945 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5080598 0.85 ROCK2 (0.40) TP53ROCK2ROCK1BRD4HSD11B1
SCHEMBL5086472 0.79 ROCK2 (0.59) ROCK2ROCK1MEN1KMT2AKDM4E
SCHEMBL5083135 0.78 CHRM1 (0.43) TP53ROCK2ROCK1HSD11B1ALDH1A1
SCHEMBL7328966 0.78 ALDH1A1 (0.41) TP53ROCK2ROCK1BRD4HSD11B1
SCHEMBL4727409 0.72 POLB (0.47) TP53ROCK2ROCK1BRD4ALDH1A1
SCHEMBL4729409 0.71 ROCK2 (0.60) ROCK2ROCK1MEN1KMT2AKDM4E
SCHEMBL4726942 0.70 TAAR1 (0.46) ROCK2ROCK1ALDH1A1MEN1KMT2A
SCHEMBL4727540 0.68 FABP6 (0.47) ROCK2ROCK1ALDH1A1MEN1KMT2A
SCHEMBL4783168 0.68 ROCK2 (0.68) TP53ROCK2ROCK1MEN1KMT2A
SCHEMBL4729584 0.67 ROCK2 (0.59) TP53ROCK2ROCK1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008021210-A2 METHODS AND COMPOSITIONS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS COMBINATORX, INCORPORATED (US) 2008-02-21 WO disclosed